Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide extension study in Parkinson's disease
NCT01286935Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Aug 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Aug 2007; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01286935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01286935.